论文期刊

取消

高级检索

检索历史清除

首页> Human pathology> Sarcomatoid features, necrosis, and grade are prognostic factors in metastatic clear cell renal cell carcinoma with vascular endothelial growth factor-targeted therapy.

Sarcomatoid features, necrosis, and grade are prognostic factors in metastatic clear cell renal cell carcinoma with vascular endothelial growth factor-targeted therapy.

导出 LinkOut

翻译打印收藏纠错

作者： Ji Young,Park ^[1] ; Jae-Lyun,Lee ^[2] ; Seunghee,Baek ^[3] ; Soo-Heang,Eo ^[4] ; Heounjeong,Go ^[1] ; Jae Y,Ro ^[5] ; Yong Mee,Cho ^[6]

作者单位： Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 138-736, Republic of Korea. ^[1] Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 138-736, Republic of Korea. ^[2] Department of Clinical Epidemiology and Biostatistics, Asan Medical Center, University of Ulsan College of Medicine, Seoul 138-736, Republic of Korea. ^[3] Department of Statistics, Korea University, Seoul 136-701, Republic of Korea. ^[4] Department of Pathology and Genomic Medicine, The Methodist Hospital and Weill Medical College of Cornell University, Houston, TX 77030. ^[5] Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 138-736, Republic of Korea. Electronic address: yongcho@amc.seoul.kr. ^[6]

关键词 Clinicopathological factors Metastatic clear cell renal cell carcinoma Prognosis Tyrosine kinase inhibitors Vascular endothelial growth factor

主题词成年人(Adult);老年人(Aged);癌, 肾细胞(Carcinoma, Renal Cell);无病生存(Disease-Free Survival);女(雌)性(Female);人类(Humans);肾肿瘤(Kidney Neoplasms);男(雄)性(Male);中年人(Middle Aged);坏死(Necrosis);预后(Prognosis);蛋白激酶抑制剂(Protein Kinase Inhibitors);回顾性研究(Retrospective Studies);存活率(Survival Rate);治疗结果(Treatment Outcome);血管内皮生长因子A(Vascular Endothelial Growth Factor A)

DOI 10.1016/j.humpath.2014.02.019

PMID 24784922

发布时间 2014-06-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览129

Human pathology

Human pathology

2014年45卷7期

1437-44页

相似文献

中文期刊
外文期刊
学位论文
会议论文

特别提示：本网站仅提供医学学术资源服务，不销售任何药品和器械，有关药品和器械的销售信息，请查阅其他网站。

客服热线：4000-115-888 转3 (周一至周五：8:00至17:00)
|
客服邮箱：yiyao@wanfangdata.com.cn

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

官方微信

万方医学小程序

关于我们网站地图知识产权

北京万方数据股份有限公司

万方数据电子出版社

京ICP证010071号

京公网安备11010802020237号

京ICP备08100800号-1

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

new翻译充值订阅收藏移动端

官方微信

万方医学小程序

调查问卷